Canaccord Genuity Believes Five9 (NASDAQ: FIVN) Won’t Stop Here

Canaccord Genuity analyst David Hynes reiterated a Buy rating on Five9 (NASDAQ: FIVN) on February 21 and set a price target of $31. The company’s shares closed yesterday at $29.70, close to More »

Lemaitre Vascular Receives a Hold from Canaccord Genuity

Canaccord Genuity analyst Jason Mills reiterated a Hold rating on Lemaitre Vascular (NASDAQ: LMAT) on February 21 and set a price target of $33. The company’s shares closed yesterday at $35.79. According More »